Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP)
- Investigators of ENVELOP Study
Research output: Contribution to journal › Article › peer-review
1
Link opens in a new tab
Citation
(Scopus)